(CNTA) Centessa - Performance 49.7% in 12m
CNTA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-14.32%
#37 in Peer-Group
Rel. Strength
84.99%
#1116 in Stock-Universe
Total Return 12m
49.66%
#22 in Peer-Group
Total Return 5y
-39.45%
#49 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 19.03 USD |
| 52 Week Low | 8.58 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 59.03 |
| Buy/Sell Signal +-5 | 0.24 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CNTA (49.7%) vs XBI (-10.7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.32% | 68% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.6% | -8.81% | 144% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.71% | -3.57% | 32.5% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.36% | 31.7% | -6.18% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.76% | -8.64% | 0.27% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.5% | 65.3% | -5.65% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
-0.49% | 55.9% | -10.1% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
3.44% | 35.3% | 14.7% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CNTA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CNTA
| Total Return (including Dividends) | CNTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.79% | 2.27% | 4.52% |
| 3 Months | -0.45% | 6.30% | 10.43% |
| 12 Months | 49.66% | -10.68% | 14.67% |
| 5 Years | -39.45% | -26.13% | 109.23% |
| Trend Score (consistency of price movement) | CNTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 45.3% | 5.5% | 79.1% |
| 3 Months | 19.5% | 74.3% | 94.2% |
| 12 Months | 7.1% | -84.7% | 44.4% |
| 5 Years | 15.7% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th50.50 | -3.97% | -6.03% |
| 3 Month | %th44.50 | -6.36% | -9.86% |
| 12 Month | %th89.50 | 67.55% | 30.51% |
| 5 Years | %th79.00 | -6.80% | -61.21% |
FAQs
Does Centessa (CNTA) outperform the market?
Yes,
over the last 12 months CNTA made 49.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.68%.
Over the last 3 months CNTA made -0.45%, while XBI made 6.30%.
Performance Comparison CNTA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CNTA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9% | -6.3% | -31% | 35% |
| US NASDAQ 100 | QQQ | -8.6% | -6.5% | -32.2% | 36% |
| German DAX 40 | DAX | -7.4% | -0.8% | -42.5% | 21% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -8.1% | -6% | -31.9% | 32% |
| Hongkong Hang Seng | HSI | -7.3% | -7.9% | -48.8% | 14% |
| India NIFTY 50 | INDA | -9.2% | -4.2% | -29.3% | 50% |
| Brasil Bovespa | EWZ | -10.1% | -9.3% | -53.9% | 37% |
CNTA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.7% | -7.8% | -36.1% | 22% |
| Consumer Discretionary | XLY | -8.5% | -3.9% | -23.8% | 29% |
| Consumer Staples | XLP | -8.1% | -1.4% | -30.6% | 39% |
| Energy | XLE | -7.9% | -6.1% | -24.9% | 53% |
| Financial | XLF | -9.3% | -5.4% | -34.7% | 20% |
| Health Care | XLV | -9.4% | -5.3% | -25% | 54% |
| Industrial | XLI | -9.3% | -5.9% | -38.2% | 25% |
| Materials | XLB | -10% | -6% | -34.1% | 44% |
| Real Estate | XLRE | -5.9% | -2.5% | -29.8% | 36% |
| Technology | XLK | -8.8% | -9.7% | -33.3% | 39% |
| Utilities | XLU | -7.7% | -2.2% | -33.7% | 25% |
| Aerospace & Defense | XAR | -9.7% | -9% | -49.4% | 1% |
| Biotech | XBI | -6.4% | -4.1% | -15.5% | 60% |
| Homebuilder | XHB | -11.6% | -12.3% | -24.4% | 45% |
| Retail | XRT | -10.1% | -6.3% | -25.3% | 40% |
CNTA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -8.5% | -8.09% | -20.8% | 59% |
| Natural Gas | UNG | -0.2% | 8.6% | -13.6% | 58% |
| Gold | GLD | -7.7% | -0.5% | -50.1% | 7% |
| Silver | SLV | -7.6% | -5.4% | -46.3% | 28% |
| Copper | CPER | -10.1% | -5.7% | -49.4% | 35% |
CNTA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -8.1% | -5.3% | -27.2% | 48% |
| iShares High Yield Corp. Bond | HYG | -7.3% | -3% | -28.9% | 39% |